The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Alliance News Detail


Oxford BioDynamics Raises GBP7.1 Million Ahead Of AIM Admission (ALLIPO)

[ 01 Dec 2016 10:21 ]

LONDON (Alliance News) - Oxford BioDynamics PLC on Thursday said it has conditionally raised GBP7.1 million ahead of its listing on London's AIM market, due to take place next week.

The company makes epigenetic biomarkers designed to accelerate the drug discovery and development process. It said the outsourced biomarker and companion diagnostic markets together are estimated to be worth approximately USD6 billion and are forecast to grow at a clip of 19% per year to 2018.

Oxford BioDynamics issued 4.5 million shares at 158.00 pence per share to raise the funds for the company. Another 8.2 million existing shares were sold by existing shareholders, meaning the total gross value of the placing was GBP20.0 million. The company's market capitalisation upon admission will be around GBP136.0 million.

It expects its shares to start trading on AIM on Tuesday next week.

"By further strengthening our balance sheet, we are now ideally positioned to accelerate our growth strategy at a time where we believe that there are significant opportunities for the EpiSwitchâ„¢ platform in helping the pharmaceutical industry improve R&D productivity, and the success rate of clinical trials," said Chief Executive Christian Hoyer Millar.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.


Oxford BioDynamics Raises GBP7.1 Million Ahead Of AIM Admission (ALLIPO) - Alliance News

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds